Susquehanna International Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.07M | Buy |
48,200
+1,600
| +3% | +$38.2K | ﹤0.01% | 7707 |
|
|
2025
Q4 | $1.24M | Sell |
46,600
-313,600
| -87% | -$7.49M | ﹤0.01% | 6670 |
|
|
2025
Q3 | $7.69M | Buy |
360,200
+307,400
| +582% | +$7.27M | ﹤0.01% | 3400 |
|
|
2025
Q2 | $1.14M | Sell |
52,800
-24,900
| -32% | -$463K | ﹤0.01% | 7109 |
|
|
2025
Q1 | $1.29M | Sell |
77,700
-62,700
| -45% | -$1.14M | ﹤0.01% | 6612 |
|
|
2024
Q4 | $2.58M | Buy |
140,400
+52,300
| +59% | +$844K | ﹤0.01% | 4754 |
|
|
2024
Q3 | $1.35M | Buy |
88,100
+37,400
| +74% | +$624K | ﹤0.01% | 6143 |
|
|
2024
Q2 | $824K | Sell |
50,700
-122,800
| -71% | -$1.98M | ﹤0.01% | 7053 |
|
|
2024
Q1 | $3.21M | Buy |
173,500
+85,400
| +97% | +$2.12M | ﹤0.01% | 4389 |
|
|
2023
Q4 | $2.76M | Sell |
88,100
-532,300
| -86% | -$12.7M | ﹤0.01% | 4724 |
|
|
2023
Q3 | $12.9M | Buy |
620,400
+564,100
| +1,002% | +$15.3M | ﹤0.01% | 2237 |
|
|
2023
Q2 | $1.35M | Buy |
56,300
+13,900
| +33% | +$309K | ﹤0.01% | 5999 |
|
|
2023
Q1 | $798K | Buy |
42,400
+19,900
| +88% | +$379K | ﹤0.01% | 7419 |
|
|
2022
Q4 | $358K | Sell |
22,500
-90,100
| -80% | -$1.41M | ﹤0.01% | 8670 |
|
|
2022
Q3 | $1.84M | Sell |
112,600
-176,800
| -61% | -$2.86M | ﹤0.01% | 5083 |
|
|
2022
Q2 | $4.08M | Buy |
289,400
+37,200
| +15% | +$694K | ﹤0.01% | 3520 |
|
|
2022
Q1 | $6.11M | Buy |
252,200
+76,300
| +43% | +$1.85M | ﹤0.01% | 3310 |
|
|
2021
Q4 | $4.11M | Buy |
175,900
+7,300
| +4% | +$147K | ﹤0.01% | 4089 |
|
|
2021
Q3 | $2.8M | Sell |
168,600
-130,300
| -44% | -$2.51M | ﹤0.01% | 5096 |
|
|
2021
Q2 | $7.29M | Sell |
298,900
-456,300
| -60% | -$10.3M | ﹤0.01% | 3374 |
|
|
2021
Q1 | $19.5M | Buy |
755,200
+592,800
| +365% | +$26.1M | ﹤0.01% | 1905 |
|
|
2020
Q4 | $8.68M | Sell |
162,400
-63,900
| -28% | -$3.17M | ﹤0.01% | 2666 |
|
|
2020
Q3 | $9.34M | Buy |
226,300
+50,600
| +29% | +$2.19M | ﹤0.01% | 2264 |
|
|
2020
Q2 | $8.52M | Buy |
175,700
+77,600
| +79% | +$3.73M | ﹤0.01% | 2337 |
|
|
2020
Q1 | $4.14M | Sell |
98,100
-454,200
| -82% | -$18.7M | ﹤0.01% | 2820 |
|
|
2019
Q4 | $23.6M | Sell |
552,300
-6,700
| -1% | -$291K | 0.01% | 1272 |
|
|
2019
Q3 | $20.1M | Buy |
559,000
+13,200
| +2% | +$400K | 0.01% | 1323 |
|
|
2019
Q2 | $14.6M | Buy |
545,800
+23,300
| +4% | +$595K | 0.01% | 1536 |
|
|
2019
Q1 | $14M | Sell |
522,500
-203,000
| -28% | -$4.74M | 0.01% | 1465 |
|
|
2018
Q4 | $11.7M | Sell |
725,500
-179,600
| -20% | -$3.49M | ﹤0.01% | 1463 |
|
|
2018
Q3 | $18.8M | Buy |
905,100
+359,200
| +66% | +$5.65M | 0.01% | 1372 |
|
|
2018
Q2 | $8.34M | Sell |
545,900
-359,500
| -40% | -$6.41M | ﹤0.01% | 2124 |
|
|
2018
Q1 | $20.3M | Buy |
905,400
+407,900
| +82% | +$11.3M | 0.01% | 1198 |
|
|
2017
Q4 | $15M | Sell |
497,500
-18,400
| -4% | -$588K | 0.01% | 1477 |
|
|
2017
Q3 | $19.4M | Sell |
515,900
-88,400
| -15% | -$2.88M | 0.01% | 1249 |
|
|
2017
Q2 | $16.9M | Sell |
604,300
-338,900
| -36% | -$10.1M | 0.01% | 1280 |
|
|
2017
Q1 | $32.4M | Sell |
943,200
-324,900
| -26% | -$11.5M | 0.02% | 776 |
|
|
2016
Q4 | $36.6M | Buy |
1,268,100
+400,600
| +46% | +$10.6M | 0.02% | 696 |
|
|
2016
Q3 | $27.6M | Hold |
867,500
| – | – | 0.01% | 811 |
|
|
2016
Q2 | $28.2M | Sell |
867,500
-471,200
| -35% | -$15.8M | 0.02% | 778 |
|
|
2016
Q1 | $37.4M | Buy |
1,338,700
+373,200
| +39% | +$8.14M | 0.02% | 650 |
|
|
2015
Q4 | $34.4M | Buy |
965,500
+106,500
| +12% | +$3.75M | 0.02% | 793 |
|
|
2015
Q3 | $28.4M | Buy |
859,000
+291,400
| +51% | +$12.1M | 0.01% | 946 |
|
|
2015
Q2 | $23.8M | Sell |
567,600
-180,800
| -24% | -$7M | 0.01% | 1158 |
|
|
2015
Q1 | $24.4M | Buy |
748,400
+197,200
| +36% | +$6.78M | 0.01% | 1090 |
|
|
2014
Q4 | $17.5M | Buy |
551,200
+60,800
| +12% | +$1.72M | 0.01% | 1459 |
|
|
2014
Q3 | $12.1M | Sell |
490,400
-48,300
| -9% | -$1.13M | ﹤0.01% | 1901 |
|
|
2014
Q2 | $12.2M | Sell |
538,700
-19,100
| -3% | -$399K | 0.01% | 1903 |
|
|
2014
Q1 | $13.6M | Buy |
557,800
+289,500
| +108% | +$7.32M | 0.01% | 1663 |
|
|
2013
Q4 | $6.71M | Sell |
268,300
-34,200
| -11% | -$807K | ﹤0.01% | 2533 |
|
|
2013
Q3 | $8.31M | Sell |
302,500
-107,600
| -26% | -$2.25M | ﹤0.01% | 2097 |
|
|
2013
Q2 | $7.44M | Buy |
+410,100
| New | +$5.65M | ﹤0.01% | 2147 |
|
Other funds holding ACAD
BBA
VPM
RI
VCM
PAI
Susquehanna International Group's ACAD Position: Q1 2026 in Review
Susquehanna International Group increased its Acadia Pharmaceuticals (ACAD) stake by 117% in Q1 2026, buying an estimated $577K and bringing the position to 44,792 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #7897.
Susquehanna International Group first reported a position in ACAD in Q2 2013 and has held it in 50 quarters since. The position peaked at $32.3M in Q4 2014. 342 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.
- Susquehanna International Group held 44,792 shares of Acadia Pharmaceuticals worth $997K as of Q1 2026.
- Susquehanna International Group bought 24,140 Acadia Pharmaceuticals shares in Q1 2026, an estimated $577K.
- Acadia Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7897 holding.
- Susquehanna International Group first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- Susquehanna International Group's Acadia Pharmaceuticals position peaked at $32.3M in Q4 2014.
- 342 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.